The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy
Condition(s):Stargardt DiseaseLast Updated:August 3, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Stargardt DiseaseLast Updated:August 3, 2018Completed
Condition(s):Stargardt’s DiseaseLast Updated:April 14, 2022Terminated
Condition(s):Stargardt Disease; Stargardt Macular Degeneration; Stargardt Macular Dystrophy; Autosomal Recessive Stargardt Disease 1 (ABCA4-related)Last Updated:January 26, 2024Recruiting
Condition(s):Stargardt Disease; Stargardt Disease 1; Fundus Flavimaculatus; Macular Degeneration, Stargardt; Macular Dystrophy With Flecks, Type 1Last Updated:January 6, 2023Recruiting
Condition(s):Dry AMD; Stargardt Disease 1Last Updated:February 23, 2021Completed
Condition(s):Stargardt Disease; Macular AtrophyLast Updated:May 19, 2021Completed
Condition(s):Stargardt Disease 1Last Updated:November 9, 2023Active, not recruiting
Condition(s):Stargardt Disease; Stargardt Macular Degeneration; Stargardt Macular Dystrophy; Autosomal Recessive Stargardt Disease 1 (ABCA4-related)Last Updated:January 26, 2024Enrolling by invitation
Condition(s):Stargardt’s DiseaseLast Updated:January 10, 2024Active, not recruiting
Condition(s):Stargardt’s Macular DystrophyLast Updated:July 7, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.